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Introduction
In humans, pituitary adenomas are classified into two
large groups of tumours: clinically functioning and
non-functioning adenomas, according to whether or
not an endocrine syndrome is present [1]. A third of all
pituitary adenomas are not associated with either clin-
ical or biochemical evidence of hormone excess. The
Silent Corticotroph Adenoma (SCA) is a pituitary ade-
noma variant characterized by the immunoreactivity
for adrenocorticotropic hormone (ACTH) and related
peptides such as β-endorphin an β-lipotrophin, despite
the fact that the patients with such adenoma don't show
clinical signs of Cushing's disease or increased serum
levels reflecting excess ACTH secretion [1].
SCA is morphologically indistinguishable from
functioning corticotroph adenoma, therefore a complete
immunohistochemical analysis of the tumour associated
with clinical evaluation is essential for an accurate diag-
nosis [1]. SCA has been postulated to either secrete
structurally abnormal ACTH that is inactive but
detectable by immunohistochemistry or radioim-
munoassay, or to secrete ACTH intermittently or at low
levels continuously [2].  In veterinary medicine SCA is
rarely described probably because of the lack of specif-
ic clinical signs and biochemical characterization.
Dogs with SCA are depressed, show  incoordina-
tion, weakness and progressive loss of weight and
muscle atrophy [3].
Proximal weakness, especially of the pelvic limbs,
is a well recognized complication of endocrine disor-
ders [4]. The most consistent change both during
Cushing's syndrome as well as in steroid myopathy is
a selective type II muscle fibers atrophy [4] but, to our
knowledge, a case of SCA associated with type II mus-
cle fibers atrophy has never been described.
Materials and methods 
The dog was a pit bull, male, 5 years old, showed moderate to
severe proximal muscle wasting and weakness, difficulty in step-
ping stairs and slight myalgia. The serum levels of muscle-associ-
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ated enzymes Creatine kinase (CK), Lactate dehydrogenase
(LDH), Aspartate Aminotransferase (AST) were in the normal
range. No specific constitutional signs of Cushing's syndrome
were present and serum cortisol level was normal. Further, the
ACTH stimulation test and the low dose dexamethasone suppres-
sion test didn't show any particular alteration of the adrenal gland.
A total body radiological exam and echocardiography were per-
formed but no significant alterations were seen. By contrary, at the
necropsy a 4 cm in diameter tumour mass was observed in the sella
turcica, under the base of the brain (Fig. 1). On cut surface it
showed a brownish appearance and focal areas of haemorrhages.
The brain including the tumour was promptly fixed in 10%
buffered formalin. Sections were stained with haematoxylin and
eosin to establish histological diagnosis. For the immunohisto-
chemistry, the peroxidase-antiperoxidase technique was used.
Paraffin sections 4-6 μm in thickness were immunostained for GH,
PRL, LH, FSH, TSH, β-endorphin and ACTH (Polyclonal anti-
bodies prediluted, Cell Marque Rocklin, CA, USA, and for
Ki67/MIB1 to evaluate the tumour growth characteristics
(diluted 1:100, DakoCytomation, Glostrup, Denmark). Nega-
tive controls were performed by incubating the sections with
the same dilution of normal rabbit serum as those used for the
corresponding specific antiserum. Samples from quadriceps and
temporalis muscles were taken and frozen in isopentane pre-
cooled in liquid nitrogen and stored at -80°C. Sections from
these specimens were stained using histological and histochem-
ical techniques routinely used in our laboratory and well char-
acterized in veterinary myology [5], in particular: haematoxylin
and eosin (HE), Engel trichrome, reduced nicotinamide-adenine
dinucleotide tetrazolium reductase (NADH-TR), succinate dehy-
drogenase (SDH), cytochrome oxidase (COX), and the myofib-
rillar Adenosine Triphosphatase (ATPase) reactions at pH 9.4
and 4.3. 
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Fig. 1. Brain, dog. A large tumour is present in the sella turcica,
under the base of the brain. It shows brownish appearance and
focal areas of haemorrhages.
Fig. 2. Brain, macroadenoma, dog. The tumour shows trabecular morphologic growth pattern with cells that have very distinct cytoplasm
borders and tend to touch each other in a "tile-like" arrangement. HE stain. Bar = 44μm. Fig. 3. Brain, macroadenoma, dog. Cytoplasmic
immunoreactive granules for ACTH. Immunohistochemistry, peroxidase-antiperoxidase technique. Bar = 44 μm. Fig. 4. Skeletal muscle
from limb; dog. The type II fibers (dark) are uniformly smaller that type I (light).  ATPasi PH 9,4 stain. Bar = 20 μm. Fig. 5. Skeletal
muscle from temporalis; dog. The majority of the fibers show irregular areas of loss of enzymatic activity. NADH-DR stain. Bar = 20 μm.
Results
By light microscopy, the tumour showed a trabecular
growth pattern (Fig. 2). The tumour cells had sharp
cytoplasmic borders, in a "tile-like" fashion. The cyto-
plasms were granular and  eosinophilic (Fig. 2). The
nuclei were large with coarse chromatin.
Immunohistochemical analysis demonstrated the
presence of cytoplasmic immunoreactivity for ACTH
(Fig. 3) and scattered cells positive to β-endorphin
(data not showed). The tumour was negative for all
other antibodies tested. For Ki-67 evaluation, 5 high-
power fields (×40) with the highest density of positive
nuclei were examined and a mean of 500 tumour cells
was counted. The result was expressed as percentage
of tumour cells with positive nuclei. Only nuclei with
a strongly positive label were counted. The tumour
showed increased Ki67/MIB1 labelling index exceed-
ing 3%. Basing on the histological pattern and the clin-
ical data a diagnosis of silent corticotroph adenoma
was made. 
Histological studies of the muscles showed two dif-
ferent patterns of lesions. In the limb muscle biopsies,
type II fibers, identify with the ATPase reactions at pH
4.3 and pH 9.4, were uniformly smaller than type I
fibers and were at varying stages of atrophy (Fig. 4),
some Ragged Red fibers were seen on Engel trichrome
staining; NADH-TR, COX and SDH showed many
type I fibers with a intensely stained mitochondria. In
temporalis muscles, on the ATPase stains, only few
type II atrophic fibers were seen, and several irregular
areas of loss of enzymatic activity were observed in
NADH SDH and COX stains (Fig. 5). 
Discussion
A changing pattern in hormonal expression and secre-
tion by pituitary adenomas is a well recognized phe-
nomenon and the associated muscle II fibers atrophy
consistent with that described in other species [6]. In
humans and cats, atrophy is only observed in type IIB
myofibers. Dogs, however, do not have classical type
IIB myofibers and atrophy affects type IIA oxidative-
glycolytic fibers [7]. A similar pattern of muscle fiber
atrophy is found in steroid-induced myopathy in other
species [6].
The primary mechanisms of how either excessive
endogenous or exogenous corticosteroids can result in
muscle weakness and atrophy appear to be through
impairment of muscle protein balance resulting from
decreased synthesis of soluble and myofibrillar pro-
teins [4,6].  Corticosteroids are also known to depress
glycolysis and induce an insulin resistant state. The
selective vulnerability of type II fibers to atrophy may
be explained by the fact that type II myofibers are
more dependant on glycolysis than are type I
myofibers [4,6].
Furthermore, in temporalis muscles, core-like areas
were observed in the oxidative enzyme stains (NADH-
TR, SDH, COX). These findings may reflect mild loss
of myofibrils and altered distribution of mitochondria.
The different morphological response of temporalis
muscle may reflect the difference in composition from
limb muscles such as they be selectively involved in
masticatory muscle myositis [7-10].
In our case, because of the normal adrenal function
detected by hormones assay and functional tests, ACTH
does not induce a cortisol excess and may be, by itself,
involved in the type II muscle fibre atrophy [4].
Several biologic mechanisms have been proposed
to account for the discordance between the finding of
ACTH immunoreactivity in tumour cells and the
apparent lack of a corresponding Cushing's syndrome.
These include the production of functionally inactive
proopiomelanocortin derivates, which is either due to
faulty translation or inadequate posttranslation pro-
cessing [11]. Alternatively, secretion of ACTH by
these tumours may be intermittent and/or serum
ACTH levels so subtly elevated as to escape recording.
It should be related to the failure exocytosis and
increased intracellular disposal, by lysosomes or a
defective packing into secretory granules due to inad-
equately developed Golgi apparatus [12].
For these reasons, despite type II fibers atrophy is
generally attributed to glucocorticoid excess, an
ACTH excess has been hypothesized to have
myophatic actions that are separate from those of glu-
cocorticoids but such pathogenic mechanism of ACTH
remains obscure [4].
In conclusion, this case suggest that, in absence of
specific clinical signs and biochemical changes, the
presence of muscle II fibers atrophy can be related to
an excess of inactive ACTH production occurring dur-
ing SCA, if so, this results could help to understand
similar disorders in human medicine as well.
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